Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 9/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.37 |
| ▸ | SPHK2 | Q9NRA0 | 5/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8377172 | 1.00 | MEN1 (0.43) | MEN1KMT2AMAPK1CYP2C9MAPT | |
| SCHEMBL3761254 | 0.99 | MEN1 (0.42) | MEN1KMT2AMAPK1CYP2C9MAPT | |
| SCHEMBL10348016 | 0.99 | MEN1 (0.42) | MEN1KMT2AMAPK1CYP2C9MAPT | |
| SCHEMBL3761250 | 0.99 | MEN1 (0.42) | MEN1KMT2AMAPK1CYP2C9MAPT | |
| SCHEMBL9052415 | 0.99 | MEN1 (0.42) | MEN1KMT2AMAPK1CYP2C9MAPT | |
| SCHEMBL3799919 | 0.99 | MEN1 (0.42) | MEN1KMT2AMAPK1CYP2C9MAPT | |
| SCHEMBL9052414 | 0.99 | MEN1 (0.42) | MEN1KMT2AMAPK1CYP2C9MAPT | |
| SCHEMBL3799918 | 0.99 | MEN1 (0.42) | MEN1KMT2AMAPK1CYP2C9MAPT | |
| SCHEMBL10348634 | 0.97 | MEN1 (0.41) | MEN1KMT2AMAPK1CYP2C9MAPT | |
| SCHEMBL10653108 | 0.97 | MEN1 (0.41) | MEN1KMT2AMAPK1CYP2C9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | DIC CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | DIC CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| EP-3470496-A1 | SPECTACLES WITH REMOTELY ACTIVATABLE DARKENING | Lapanik, Valeri I. (BY) | 2019-04-17 | — | — | EP | disclosed |
| US-10224620-B2 | Antenna having radio frequency liquid crystal (RFLC) mixtures with high RF tuning, broad thermal operating ranges, and low viscosity | KYMETA CORPORATION (US) | 2019-03-05 | — | — | US | disclosed |
| US-10023798-B2 | Liquid crystal compositions comprising mesogenic compounds, and devices for high-frequency thechnology | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-07-17 | — | — | US | disclosed |
| US-20170051202-A1 | LIQUID CRYSTAL COMPOSITIONS COMPRISING MESOGENIC COMPOUNDS, AND DEVICES FOR HIGH-FREQUENCY THECHNOLOGY | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-02-23 | — | — | US | disclosed |
| US-20080129934-A1 | OPTICAL COMPENSATION FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY | KONICA MINOLTA OPTO, INC. (JP) | 2008-06-05 | — | — | US | disclosed |
| US-7345725-B2 | Optical compensation film, polarizing plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2008-03-18 | — | — | US | disclosed |
| US-7218367-B2 | Optical compensation sheet and liquid crystal display | KONICA CORPORATION (JP) | 2007-05-15 | — | — | US | disclosed |
| US-7199848-B2 | Optical compensation sheet and liquid crystal display | KONICA CORPORATION (JP) | 2007-04-03 | — | — | US | disclosed |
| US-7158200-B2 | Optical compensation sheet and liquid crystal display | KONICA CORPORATION (JP) | 2007-01-02 | — | — | US | disclosed |
| US-5958290-A | ELECTROOPTICAL APPARATUS WITH DIELECTRIC LIQUID CRYSTALS FOR RADIATION TRANSPARENT MEDIUM | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1999-09-28 | — | — | US | disclosed |
| WO-1996006061-A2 | LATERALLY SUBSTITUTED CHLOROARENES, THEIR MANUFACTURE AND MIXTURES CONTAINING THEM | WOJSKOWA AKADEMIA TECHNICZNA (PL) | 1996-02-29 | — | — | WO | disclosed |
| WO-1996006073-A1 | LIQUID CRYSTAL MATERIALS | WOJSKOWA AKADEMIA TECHNICZNA (PL) | 1996-02-29 | — | — | WO | disclosed |
| US-5344587-A | Nitriles | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1994-09-06 | — | — | US | disclosed |
| WO-1991005029-A1 | ELECTRO-OPTICAL LIQUID CRYSTAL SYSTEM | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1991-04-18 | — | — | WO | disclosed |
| EP-0226592-B1 | LIQUID CRYSTAL PHASE | MERCK PATENT GmbH (DE) | 1989-09-06 | — | — | EP | disclosed |
| US-4818428-A | MIXTURE OF POLAR AND APOLAR COMPOUNDS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-04-04 | — | — | US | disclosed |
| EP-0226592-A1 | LIQUID CRYSTAL PHASE. | MERCK PATENT GMBH (DE) | 1987-07-01 | — | — | EP | disclosed |
| WO-1986005799-A1 | LIQUID CRYSTAL PHASE | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | TTI2, CCT4, CCT2 | MEN1 2827/4885KMT2A 3777/4885MAPK1 1226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.